Sisram Medical Ltd.

As of December 31, 2025, Sisram Medical Ltd. carries a market capitalization of 1.97B, placing it among publicly traded companies globally. Its enterprise value stands at 2.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sisram Medical Ltd.'s next confirmed earnings release is scheduled for March 24, 2027.

As of December 31, 2025, Sisram Medical Ltd. has 468.34M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Sisram Medical Ltd. maintains a current ratio of 2.60, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, Sisram Medical Ltd.'s stock has declined approximately 60.65% over the past 52 weeks. The 50-day moving average sits at 2.00, while the 200-day moving average is 2.91.

As of December 31, 2025, Sisram Medical Ltd. holds 552.31M in cash and equivalents against 402.74M in total debt, resulting in a net debt position of -468.36M. Total book value stands at 3.73B, with working capital of 1.32B providing operational flexibility.